BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
8/22/2014 5:28:00 PM | Browse: 1421 | Download: 1621
Publication Name World Journal of Clinical Oncology
Manuscript ID 8178
Country Finland
ISSN 2218-4333 (online)
Open Access
Copyright
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com
Category Oncology
Manuscript Type Topic Highlights
Article Title Toremifene in the treatment of breast cancer
Manuscript Source Invited Manuscript
All Author List Mika VJ Mustonen, Seppo Pyrhönen and Pirkko-Liisa Kellokumpu-Lehtinen
Funding Agency and Grant Number
Corresponding Author Mika VJ Mustonen, PhD, Orion Corporation, Orion Pharma, Orionintie 1, FIN-02101, Espoo, Finland. mika.mustonen@orionpharma.com
Key Words Breast cancer; Toremifene; tamoxifen; Adjuvant treatment; Advanced breast cancer
Core Tip Toremifene is safe and effective in the treatment of breast cancer. Toremifene and tamoxifen are equivalently effective in the treatment of breast cancer, although some studies show an advantage for toremifene. Safety and tolerability is also broadly equivalent, although toremifene may cause fewer uterine neoplasms, serious vascular adverse events and has a more beneficial effect on plasma lipids than does tamoxifen.
Publish Date 2014-08-01 15:17
Citation Mustonen MVJ, Pyrhönen S, Kellokumpu-Lehtinen PL. Toremifene in the treatment of breast cancer. World J Clin Oncol 2014; 5(3): 393-405
URL http://www.wjgnet.com/2218-4333/full/v5/i3/393.htm
DOI http://dx.doi.org/10.5306/wjco.v5.i3.393
Full Article (PDF) WJCO-5-393.pdf
Full Article (Word) WJCO-5-393.doc